222 related articles for article (PubMed ID: 11797078)
1. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.
Rowland NE; Mukherjee M; Robertson K
Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078
[TBL] [Abstract][Full Text] [Related]
2. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine.
Williams CM; Kirkham TC
Pharmacol Biochem Behav; 2002; 71(1-2):333-40. PubMed ID: 11812541
[TBL] [Abstract][Full Text] [Related]
3. Synergistic efects of opioid and cannabinoid antagonists on food intake.
Kirkham TC; Williams CM
Psychopharmacology (Berl); 2001 Jan; 153(2):267-70. PubMed ID: 11205430
[TBL] [Abstract][Full Text] [Related]
4. Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats.
Pietras TA; Rowland NE
Eur J Pharmacol; 2002 May; 442(3):237-9. PubMed ID: 12065077
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.
Tallett AJ; Blundell JE; Rodgers RJ
Pharmacol Biochem Behav; 2009 Jan; 91(3):358-66. PubMed ID: 18755211
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake.
Verty AN; McFarlane JR; McGregor IS; Mallet PE
Neuropharmacology; 2004 Sep; 47(4):593-603. PubMed ID: 15380376
[TBL] [Abstract][Full Text] [Related]
7. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
Simiand J; Keane M; Keane PE; Soubrié P
Behav Pharmacol; 1998 Mar; 9(2):179-81. PubMed ID: 10065938
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.
Tallett AJ; Blundell JE; Rodgers RJ
Physiol Behav; 2008 Jun; 94(3):422-31. PubMed ID: 18394662
[TBL] [Abstract][Full Text] [Related]
9. Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
Rowland NE; Marshall M; Robertson K
Eur J Pharmacol; 2001 May; 419(1):61-4. PubMed ID: 11348631
[TBL] [Abstract][Full Text] [Related]
10. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
11. Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.
Rowland NE; Marshall M; Roth JD
Psychopharmacology (Berl); 2000 Mar; 149(1):77-83. PubMed ID: 10789886
[TBL] [Abstract][Full Text] [Related]
12. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
[TBL] [Abstract][Full Text] [Related]
13. Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716.
Vacca G; Serra S; Brunetti G; Carai MA; Gessa GL; Colombo G
Eur J Pharmacol; 2002 Jun; 445(1-2):55-9. PubMed ID: 12065194
[TBL] [Abstract][Full Text] [Related]
14. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
Gallate JE; Mallet PE; McGregor IS
Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.
Verty AN; McFarlane JR; McGregor IS; Mallet PE
Endocrinology; 2004 Jul; 145(7):3224-31. PubMed ID: 15033920
[TBL] [Abstract][Full Text] [Related]
16. Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2010 Feb; 207(1):174-81. PubMed ID: 19818809
[TBL] [Abstract][Full Text] [Related]
17. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
18. Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.
Grottick AJ; Whelan K; Sanabria EK; Behan DP; Morgan M; Sage C
Psychopharmacology (Berl); 2015 Jun; 232(11):1973-82. PubMed ID: 25524140
[TBL] [Abstract][Full Text] [Related]
19. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
